The American College of Chest Physicians (CHEST) was awarded a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to improve diagnostic excellence in interstitial lung disease (ILD).
Syncona buys gene therapy company; Oryzon’s €45M financing agreement; InDex scraps PhIII drug
Syncona scoops up Freeline: British life sciences investor Syncona said Wednesday it agreed to buy gene therapy maker Freeline Therapeutics through a new portfolio company.